To evaluate and compare beta lactam and non beta lactam antibiotics against streptococcus mutans

Comparative Evaluation Of Beta Lactam And Non-Beta Lactam Antibiotics Against Streptococcus Mutans Associated With Dental Caries In Children. - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/04/085750

Enrollment

Registered

2025-04-28

Start date

Unknown

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: Beta lactam antibiotics: (Ampicillin, Cefotaxime, Amoxicillin, Cefazolin Control Intervention1: Non Beta lactam antibiotics: Erythromycin, Lincomycin, Clindamycin and Vancomycin

Eligibility

Inclusion criteria

Inclusion criteria: Age group selected between 6-10 years. Children with good systemic health. Children who are having atleast one decayed primary molar. Children who are willing for the study and are co-operative. Children whose parents have given a consent are considered.

Exclusion criteria

Exclusion criteria: Antibiotic consumption during the last 6 months. Uncooperative patients during dental treatment

Design outcomes

Primary

Measure	Time frame
tis to evaluate the antimicrobial efficacy of beta lactam antibiotics and non beta lactam antibiotics against Streptococcus Mutans associated with dental caries in childrenTimepoint: 1 min	—

Secondary

Measure	Time frame
To evaluate susceptible or sensitive strains of streptococcus mutansTimepoint: 5 mins	—

Countries

India

Contacts

Public ContactDr. Shrutha S P

AME S Dental college and hospital, bijangera, raichur, karnataka

raghavendrahavale@yahoo.co.in944840730

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026